Regulatory Post Marketing Surveillance Study in Korea

Visanne® (Dienogest 2mg) Regulatory Post Marketing Surveillance Study in Korea

The objective of the study is to investigate and collect post marketing data on the safety and efficacy of Visanne at follow-up visit after about 6 months of treatment and - for a subset of patients - at optional long-term follow-up visit after about 1 year of treatment under daily practice treatment conditions in Korean women and to obtain data on drug utilization on treatment for endometriosis.

Inclusion Criteria:

• Signed and dated informed consent
• Women diagnosed by a physician as having endometriosis
• Women who are prescribed Visanne(dienogest 2mg)for the first time during the study period

Exclusion Criteria:

- All contraindications according to the local marketing authorization have to be considered.